Premier Biomedical, Inc.
BIEI
$0.0004
-$0.0002-33.33%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Net Income | -34.30K | -181.60K | -227.00K | 68.50K | -501.70K |
| Total Depreciation and Amortization | 700.00 | 800.00 | 700.00 | 600.00 | 600.00 |
| Total Amortization of Deferred Charges | 260.90K | 43.20K | 13.50K | 2.90K | 60.20K |
| Total Other Non-Cash Items | -363.80K | 61.10K | 115.90K | -158.20K | 356.70K |
| Change in Net Operating Assets | 65.50K | -21.70K | -10.10K | 18.40K | -42.20K |
| Cash from Operations | -71.00K | -98.20K | -107.10K | -67.80K | -126.40K |
| Capital Expenditure | 0.00 | 0.00 | -2.10K | -2.80K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -2.10K | -2.80K | 0.00 |
| Total Debt Issued | 25.00K | 128.40K | 115.00K | 65.00K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 150.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.00K | 128.40K | 115.00K | 65.00K | 150.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.00K | 30.20K | 5.80K | -5.60K | 23.60K |
